Title of article
Treatment of motor dysfunction in Parkinsonʹs disease: an overview
Author/Authors
Stéphane Thobois، نويسنده , , Florence Delamarre-Damier، نويسنده , , Pascal Derkinderen، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2004
Pages
13
From page
269
To page
281
Abstract
Levodopa remains the most effective treatment for Parkinsonʹs disease (PD). However, the use of this drug is complicated by several adverse effects, in particular motor fluctuations and dyskinesias. Drugs providing more continuous dopaminergic stimulation and surgical approaches, such as deep-brain stimulation, have an important ameliorative effect on these problems. Despite these advances, the progression of the disease remains unaffected and strategies that slow or stop the neurodegenerative process are currently not available. Nevertheless, several compounds or surgical procedures are candidates for being neuroprotective and some of them are under evaluation.
Keywords
neuroprotection , Parkinson’s disease , Levodopa , Dopamine agonists , IMAO-B , Deep-brain stimulation
Journal title
Clinical Neurology and Neurosurgery
Serial Year
2004
Journal title
Clinical Neurology and Neurosurgery
Record number
464160
Link To Document